Press release
Next Generation Sequencing Market Forecast 2017-2021
According to the new report "Global Next Generation Sequencing Market Assessment & Forecast: 2017 - 2021" by SA-Business Research & Consulting Group, Illumina leads the market with more than 75% market share. The global next generation sequencing market was valued at US$ 3,509.6 Million in 2016 and is expected to reach US$ 7,527.0 Million by 2021 growing at a compounded annual growth rate of 16.02%.
Illumina entered the NGS market through the acquisition of Solexa, Inc. in 2006. Since then, the company has introduced numerous variants of the sequencing-by-synthesis (SBS) technology. By far, Illumina has the largest installed base as compared to all other manufacturers worldwide. Illumina has developed strong distribution channels throughout the globe for effective distribution of its sequencing systems. Currently 54% of the company’s revenue is generated from the U.S., while 24% and 17% from Europe and Asia-Pacific regions respectively. In 2011, the company opened new office in Sao Paolo, Brazil to target the Latin America region where it has sparse market presence. In 2016, the company signed reseller agreement with GenDx; which allows the company to become a non-exclusive reseller of Illumina products in Benelux, Italy, United Kingdom, Germany and Finland. In 2015, Illumina announced its plans to invest in building a new European headquarters in Cambridge, U.K. This would strengthen its hold on the steadily growing Europe market.
Request Free Report Sample@ http://www.sa-brc.com/Global-Next-Generation-Sequencing-Market-Assessment--Forecast-2017---2021/sample32
The report also maintains major focus on key player analysis in next generation sequencing market. Next generation sequencing (NGS) technology market is in a constant flux of change due to continuous technology upgrades. At least five companies are currently developing novel NGS technology which may commercialize during the forecast period. Numerous companies are investing in development of novel methods for efficient and cost effective sequencing. Agilent Technologies invested US$ 80 million in LaserGen for development and commercialization of the proprietary lightning terminators technology. Genapsys is currently developing Gene Electronic Nano-Integrated Ultra-Sensitive (GENIUS) technology, a portable sequencer targeted for research and diagnostic laboratory purposes. Although the company opened early access registration in 2014, commercial launch has not yet been announced officially. Although Nabsys had closed operations in 2015 after 10 years of struggle in development of its next generation sequencing technology, the company was relaunched as Nabsys 2.0 in 2016. The company also received US$ 42 million in funding from a Chinese company Zixin Pharma. Majority of the sequencing technologies in pipeline are nanopore based.
Key players mentioned in the report include Illumina, Inc., Thermo Fisher Scientific, Inc., Oxford Nanopore, Pacific Biosciences, Qiagen N.V., Roche Sequencing, Stratos Genomics, GnuBio and others.
More Report Description And TOC@ http://www.sa-brc.com/report/Global-Next-Generation-Sequencing-Market-Assessment--Forecast-2017---2021/32
About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.
Contact Us
John Whitmore
Office No. 14,
Hermes Kunj, Mangaldas Road,
Pune, 411001
India
Phone: +91-02041210872
Email: support@sa-brc.com
Website: www.sa-brc.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next Generation Sequencing Market Forecast 2017-2021 here
News-ID: 525379 • Views: …
More Releases from SA-BRC
Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has…
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage.
Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine…
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target…
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients.
The…
More Releases for Illumina
Microarray Biochips Market is Booming Worldwide |Illumina,Qiagen,Eppendorf
HTF MI just released the Global Microarray Biochips Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Microarray Biochips Market are: Thermo Fisher Scientific,…
Metagenomics Market: Gaining Unprecedented Momentum | Illumina, PerkinElmer
IMR posted new studies guide on Metagenomics Market Insights with self-defined Tables and charts in presentable format. In the Study you may locate new evolving Trends, Drivers, Restraints, Opportunities generated via targeting market related stakeholders. The boom of the Metagenomics marketplace became specifically driven with the aid of the growing R&D spending internationally.
Metagenomics Market Size Was Valued at USD 2.05 Billion in 2023, and is Projected to Reach USD 6.31…
Bioinformatics Market: Know Opportunity Ahead | Illumina, QIAGEN, Wuxi NextCODE
The latest study released on the Global Bioinformatics Market by HTF MI Research evaluates market size, trend, and forecast to 2030. The Bioinformatics market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players in This…
Agrigenomics Market is Booming Worldwide | Illumina, LGC, Eurofins USA
Advance Market Analytics added research publication document on Worldwide Agrigenomics Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide Agrigenomics market. The study provides valuable market size data for historical (Volume** & Value) from 2018 to 2023 which is estimated and forecasted till 2028*. Some are the…
Biochips Market Emerging Trends, Size, Share, Growth may Make Driving Growth Vol …
Biochips Market Analysis Report is structured with the meticulous efforts of an innovative, enthusiastic, knowledgeable and experienced team of analysts, researchers, industry experts, and forecasters. This report also offers an in-depth overview of product specification, technology, product type and production analysis considering major factors such as Revenue, Cost, Gross and Gross Margin. Biochips Market analyses the industry based on different factors like growth trends, consumer volume, and market size, demand…
Biochips Market Share 2020-26, Illumina, PerkinElmer, QIAGEN
The latest study on the Global Biochips market report represents a deep appraisal of the international industry. The research report on the worldwide Biochips market 2020-2026 sheds light on qualitative as well as quantitative insights, historical Biochips industry status and authorized projection related to the Biochips market size. Each and every segment exhibited in this report are discovered through verifiable research methods and techniques. It also offers an in-depth overview…
